Suchergebnisse - "Multicenter Study"

PubPharm (19.307)

1

Routine rapid HIV screening in six community health centers serving populations at risk

enthalten in: Journal of general internal medicine | 2009

von Myers, J. | Modica, C. | Dufour, M. | +2

ErratumIn: J Gen Intern Med. 2010 Mar;25(3):277

2

A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction : the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial

enthalten in: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology | 2009

von Hall, A. | Jackson, B. | Farrin, A. | +108

3

Analysis of diluted vitreous samples from vitrectomy is useful in eyes with severe acute postoperative endophthalmitis

enthalten in: Ophthalmology | 2009

von Chiquet, C. | Maurin, M. | Thuret, G. | +47

4

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age : an analysis of 657 patients

enthalten in: The American journal of surgical pathology | 2009

von Collins, L. | Achacoso, N. | Nekhlyudov, L. | +9

5

Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy

enthalten in: Clinical nephrology | 2009

von Kim, S. | Oh, K. | Chin, H. | +7

6

Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch

enthalten in: Vaccine | 2009

von Glenn, G. | Thomas, D. | Poffenberger, K. | +4

7

3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions : the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)

enthalten in: JACC. Cardiovascular interventions | 2009

von Garg, S. | Serruys, P. | Onuma, Y. | +9

CommentIn: JACC Cardiovasc Interv. 2009 Dec;2(12):1236-9. - PMID 20129550

8

Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent : 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

enthalten in: JACC. Cardiovascular interventions | 2009

von Eisenstein, E. | Leon, M. | Kandzari, D. | +6

CommentIn: JACC Cardiovasc Interv. 2009 Dec;2(12):1236-9. - PMID 20129550

9

Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions : 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

enthalten in: JACC. Cardiovascular interventions | 2009

von Leon, M. | Kandzari, D. | Eisenstein, E. | +12

CommentIn: JACC Cardiovasc Interv. 2009 Dec;2(12):1236-9. - PMID 20129550

10

Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents : an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials

enthalten in: JACC. Cardiovascular interventions | 2009

von Doi, H. | Maehara, A. | Mintz, G. | +11

CommentIn: JACC Cardiovasc Interv. 2009 Dec;2(12):1276-8. - PMID 20129556

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1931]